| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
The offering is expected to close on or about April 9, 2024, subject to customary closing conditions. TD SYNNEX will not receive any of the proceeds from the sale of shares by the Selling Stockholders in the offering.
In addition, the Company has agreed to purchase from the underwriters 1,750,000 shares of common stock that are the subject of the offering at a price per share equal to the price per share to be paid by the underwriters to the Selling Stockholders (the "Concurrent Share Repurchase") under the Company's existing share repurchase program. The Company plans to fund the Concurrent Share Repurchase from existing cash on hand. The underwriters will not receive any compensation for the shares being repurchased by the Company.
Posted In: SNX
